Giuseppe Ciaramella - 31 Jan 2022 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role
President & CSO
Signature
By: /s/ Christine Bellon, Attorney-in-fact
Issuer symbol
BEAM
Transactions as of
31 Jan 2022
Net transactions value
$0
Form type
4
Filing time
02 Feb 2022, 17:00:20 UTC
Previous filing
30 Dec 2021
Next filing
04 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BEAM Stock Option (Right to Buy) Award $0 +30,000 $0.000000 30,000 31 Jan 2022 Common Stock 30,000 $69.21 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in equal monthly installments each month following the date of grant for the subsequent 48 months, subject to the reporting person's continued service with Beam Therapeutics Inc. through each vesting date.